Selected Drugs Clear All
MultiCheck Results
- 1
Interaction
Monitor/Modify Tx |
||
|
CellCept
(mycophenolate mofetil) + oxymorphone
(generic) |
||
Monitor/Modify Txmycophenolate mofetil + oxymorphone monitor respiratory rate; decr. oxymorphone start dose by at least 50%, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects) |
||
Additional Considerations |
||
|
oxymorphone
|
||
|
consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use add MAO inhibitor to Interaction Check if recent (14 days) use avoid combo with beverages or products containing ethanol and some oxymorphone extended-release (ER) tablets; combo may incr. oxymorphone release rate, levels, risk of adverse effects, including life-threatening overdose, decr. duration of efficacy |
||
|
mycophenolate mofetil
in CellCept
|
||
|
mycophenolate mofetil (prodrug) converted to mycophenolic acid |
||